Annual Interest Expense
N/A
31 December 2023
Summary:
Viking Therapeutics annual interest expense is not available.VKTX Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
N/A
30 September 2024
Summary:
Viking Therapeutics quarterly interest expense is not available.VKTX Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
N/A
30 September 2024
Summary:
Viking Therapeutics TTM interest expense is not available.VKTX TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
VKTX Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Viking Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $20.00 K(>+9900.0%) | $20.00 K(-95.0%) |
| Dec 2018 | $404.00 K(-68.5%) | $0.00(0.0%) | $404.00 K(-39.0%) |
| Sept 2018 | - | $0.00(-100.0%) | $662.00 K(-27.9%) |
| June 2018 | - | $146.00 K(-43.4%) | $918.00 K(-17.3%) |
| Mar 2018 | - | $258.00 K(0.0%) | $1.11 M(-13.6%) |
| Dec 2017 | $1.28 M(-29.1%) | $258.00 K(+0.8%) | $1.28 M(-12.1%) |
| Sept 2017 | - | $256.00 K(-24.3%) | $1.46 M(-10.8%) |
| June 2017 | - | $338.00 K(-21.9%) | $1.64 M(-10.3%) |
| Mar 2017 | - | $433.00 K(-0.3%) | $1.83 M(+0.9%) |
| Dec 2016 | $1.81 M | $434.30 K(+0.3%) | $1.81 M(+11.1%) |
| Sept 2016 | - | $432.80 K(-17.8%) | $1.63 M(+12.6%) |
| June 2016 | - | $526.80 K(+26.6%) | $1.45 M(+21.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $416.10 K(+63.9%) | $1.19 M(+21.3%) |
| Dec 2015 | $982.20 K(+56.2%) | $253.80 K(+1.2%) | $982.10 K(-7.0%) |
| Sept 2015 | - | $250.80 K(-7.2%) | $1.06 M(+2.8%) |
| June 2015 | - | $270.30 K(+30.5%) | $1.03 M(+24.2%) |
| Mar 2015 | - | $207.20 K(-36.8%) | $826.90 K(+31.5%) |
| Dec 2014 | $628.70 K(+2466.1%) | $327.90 K(+47.9%) | $628.70 K(+109.0%) |
| Sept 2014 | - | $221.70 K(+216.3%) | $300.80 K(+280.3%) |
| June 2014 | - | $70.10 K(+678.9%) | $79.10 K(+445.5%) |
| Mar 2014 | - | $9000.00(+63.6%) | $14.50 K(+74.7%) |
| Dec 2013 | $24.50 K | - | - |
| June 2013 | - | $5500.00(+292.9%) | $8300.00(+196.4%) |
| Mar 2013 | - | $1400.00(0.0%) | $2800.00(+100.0%) |
| Dec 2012 | - | $1400.00 | $1400.00 |
FAQ
- What is the all time high annual interest expense for Viking Therapeutics?
- What is the all time high quarterly interest expense for Viking Therapeutics?
- What is the all time high TTM interest expense for Viking Therapeutics?
What is the all time high annual interest expense for Viking Therapeutics?
Viking Therapeutics all-time high annual interest expense is $1.81 M
What is the all time high quarterly interest expense for Viking Therapeutics?
Viking Therapeutics all-time high quarterly interest expense is $526.80 K
What is the all time high TTM interest expense for Viking Therapeutics?
Viking Therapeutics all-time high TTM interest expense is $1.83 M